1. Natural Products
  2. Plants
  3. Ranunculaceae
  4.  Cimicifuga foetida Linn.

 Cimicifuga foetida Linn.

 Cimicifuga foetida Linn. (18):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-N0761
    Isoferulic acid 537-73-5 99.82%
    Isoferulic acid (3-Hydroxy-4-methoxycinnamic acid) is a cinnamic acid derivative that has antidiabetic activity. Isoferulic acid binds to and activates α1-adrenergic receptors (IC50=1.4 µM) to enhance secretion of β-endorphin (EC50=52.2 nM) and increase glucose use. Isoferulic acid also has anti-influenza virus activities.
    Isoferulic acid
  • HY-N6971
    Cimiracemoside C 256925-92-5 99.55%
    Cimiracemoside C is an active component of Cimicifuga racemosa, activates AMPK, has the potential activity against diabetes.
    Cimiracemoside C
  • HY-N5088
    26-Deoxycimicifugoside 214146-75-5 ≥99.0%
    26-Deoxycimicifugoside is a triterpene xylosides isolated from Cimicifuga racemosa.
  • HY-N6264
    26-Deoxyactein 264624-38-6 99.76%
    26-Deoxyactein is a constituent isolated from Cimicifuga racemosa, prevents TCDD-induced osteoblasts damage. 26-Deoxyactein inhibits increased AhR, CYP1A1 and ERK levels.
  • HY-N6872
    Actein 18642-44-9 98.58%
    Actein is a triterpene glycoside isolated from the rhizomes of Cimicifuga foetida. Actein suppresses cell proliferation, induces autophagy and apoptosis through promoting ROS/JNK activation, and blunting AKT pathway in human bladder cancer. Actein has little toxicity in vivo.
  • HY-N1541
    prim-O-Glucosylangelicain 85889-15-2
    Prim-O-Glucosylangelicain can be isolated from the rhizoma of Cimicifuga species.
  • HY-N6988
    Cimigenol 3779-59-7 99.79%
    Cimigenol is an active compound isolated from Cimicifuga, with potent anti-tumor activity.
  • HY-N7119
    Cimicifugoside 66176-93-0
    Cimicifugoside, a triterpenoid isolated from Cimicifuga simplex, is a novel specific nucleoside transport inhibitor that displays synergistic potentiation of methotrexate cytotoxicity. Cimicifugoside shows immunosuppressive activity, which is preferentially directed toward B-cell function with larger doses being required for suppression of T-cell function.
  • HY-N2042
    Cimigenol-3-O-α-L-arabinoside 161207-05-2
    Cimigenol-3-O-α-L-arabinoside is a triterpenoid isolated from Cimicifuga foetida L.
  • HY-N2097
    Cimigenoside 27994-11-2 98.90%
    Cimigenoside is an active compound from genus Cimicifuga.
  • HY-N2170
    Acetylshengmanol Arabinoside 402513-88-6 99.89%
    Acetylshengmanol Arabinoside is isolated from Cimicifugae rhizoma.
    Acetylshengmanol Arabinoside
  • HY-N3587
    Cimiside B 152685-91-1
    Cimiside B is a glycoside alkaloid with anti-inflammatory activity.
    Cimiside B
  • HY-N6907
    Dahurinol 38908-87-1 99.21%
    Dahurinol is a natural compound isolated from Cimicifuga acerina.
  • HY-N7582
    Cimicifugoside H-2 161097-77-4
    Cimicifugoside H-2 is a cyclolanostanol xyloside. Cimicifugoside H-2 can be isolated from Cimicifuga Rhizome.
    Cimicifugoside H-2
  • HY-N8715
    Cimilactone A 468733-06-4
    Cimilactone A is a cycloartane-type triterpene glycoside. Cimilactone A can be isolated from the rhizomes of Cimicifuga foetida.
    Cimilactone A
  • HY-N9331
    Cimicifugoside H-1 163046-73-9 98.87%
    Cimicifugoside H-1, a cyclolanostanol xyloside, is a major constituent of C. foetida L. extract. Cimicifugoside H-1 inhibits bone resorption and ovariectomy-induced bone loss.
    Cimicifugoside H-1
  • HY-N10047
    7,8-Didehydrocimigenol 150972-72-8
    7,8-Didehydrocimigenol is an active triterpenoid that can be isolated from Cimicifugae rhizoma. 7,8-Didehydrocimigenol inhibits TNF-α-induced VCAM-1 expression, inhibits NF-kB activity and phosphorylation of ERK1/2 and Akt, increases PPAR-γ expression. 7,8-Didehydrocimigenol can be used for the research of cardiovascular disorders such as atherosclerosis.
  • HY-N10700
    25-O-Acetylcimigenol xyloside 27994-12-3
    25-O-Acetylcimigenol xyloside is a triterpene xyloside that can be isolated from Cimicifuga racemosa.
    25-O-Acetylcimigenol xyloside